Discovery of childhood brain cancer subgroups may advance therapy
VANCOUVER _ Pediatric cancer patients are one step closer to being treated with new, less toxic and more precise drug therapies say scientists at the BC Cancer Agency's Michael Smith Genome Sciences Centre.